A clinical trial of antibody GSK1070806 in the treatment of patients with moderate to severe Crohn’s Disease A clinical trial of antibody GSK1070806 in the treatment of patients with moderate to severe Crohn’s ...
A Phase Ib/IIb, Randomised, Double Blind, Placebo-Controlled Trial to Investigate the Safety, Tolerability and Clinical Activity of Humanised Antibody GSK1070806 in the Treatment of Patients with Moderate-to-Severe Crohn’s Disease - CDAID GSK1070806 A Phase Ib/IIb, Randomised, Double Blind, Placebo-Controlled Trial to Investigate the Safety, Tolera ...